Cargando…

Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation

The intrahelical salt bridge between E/D(3.49) and R(3.50) within the E/DRY motif on helix 3 (H3) and the interhelical hydrogen bonding between the E/DRY and residues on H6 are thought to be critical in stabilizing the class A G protein-coupled receptors in their inactive state. Removal of these int...

Descripción completa

Detalles Bibliográficos
Autores principales: Capra, Valérie, Busnelli, Marta, Perenna, Alessandro, Ambrosio, Manuela, Accomazzo, Maria Rosa, Galés, Celine, Chini, Bice, Rovati, G. Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610872/
https://www.ncbi.nlm.nih.gov/pubmed/23555978
http://dx.doi.org/10.1371/journal.pone.0060475
_version_ 1782264511385829376
author Capra, Valérie
Busnelli, Marta
Perenna, Alessandro
Ambrosio, Manuela
Accomazzo, Maria Rosa
Galés, Celine
Chini, Bice
Rovati, G. Enrico
author_facet Capra, Valérie
Busnelli, Marta
Perenna, Alessandro
Ambrosio, Manuela
Accomazzo, Maria Rosa
Galés, Celine
Chini, Bice
Rovati, G. Enrico
author_sort Capra, Valérie
collection PubMed
description The intrahelical salt bridge between E/D(3.49) and R(3.50) within the E/DRY motif on helix 3 (H3) and the interhelical hydrogen bonding between the E/DRY and residues on H6 are thought to be critical in stabilizing the class A G protein-coupled receptors in their inactive state. Removal of these interactions is expected to generate constitutively active receptors. This study examines how neutralization of E(3.49/6.30) in the thromboxane prostanoid (TP) receptor alters ligand binding, basal, and agonist-induced activity and investigates the molecular mechanisms of G protein activation. We demonstrate here that a panel of full and partial agonists showed an increase in affinity and potency for E129V and E240V mutants. Yet, even augmenting the sensitivity to detect constitutive activity (CA) with overexpression of the receptor or the G protein revealed resistance to an increase in basal activity, while retaining fully the ability to cause agonist-induced signaling. However, direct G protein activation measured through bioluminescence resonance energy transfer (BRET) indicates that these mutants more efficiently communicate and/or activate their cognate G proteins. These results suggest the existence of additional constrains governing the shift of TP receptor to its active state, together with an increase propensity of these mutants to agonist-induced signaling, corroborating their definition as superactive mutants. The particular nature of the TP receptor as somehow “resistant” to CA should be examined in the context of its pathophysiological role in the cardiovascular system. Evolutionary forces may have favored regulation mechanisms leading to low basal activity and selected against more highly active phenotypes.
format Online
Article
Text
id pubmed-3610872
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36108722013-04-03 Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation Capra, Valérie Busnelli, Marta Perenna, Alessandro Ambrosio, Manuela Accomazzo, Maria Rosa Galés, Celine Chini, Bice Rovati, G. Enrico PLoS One Research Article The intrahelical salt bridge between E/D(3.49) and R(3.50) within the E/DRY motif on helix 3 (H3) and the interhelical hydrogen bonding between the E/DRY and residues on H6 are thought to be critical in stabilizing the class A G protein-coupled receptors in their inactive state. Removal of these interactions is expected to generate constitutively active receptors. This study examines how neutralization of E(3.49/6.30) in the thromboxane prostanoid (TP) receptor alters ligand binding, basal, and agonist-induced activity and investigates the molecular mechanisms of G protein activation. We demonstrate here that a panel of full and partial agonists showed an increase in affinity and potency for E129V and E240V mutants. Yet, even augmenting the sensitivity to detect constitutive activity (CA) with overexpression of the receptor or the G protein revealed resistance to an increase in basal activity, while retaining fully the ability to cause agonist-induced signaling. However, direct G protein activation measured through bioluminescence resonance energy transfer (BRET) indicates that these mutants more efficiently communicate and/or activate their cognate G proteins. These results suggest the existence of additional constrains governing the shift of TP receptor to its active state, together with an increase propensity of these mutants to agonist-induced signaling, corroborating their definition as superactive mutants. The particular nature of the TP receptor as somehow “resistant” to CA should be examined in the context of its pathophysiological role in the cardiovascular system. Evolutionary forces may have favored regulation mechanisms leading to low basal activity and selected against more highly active phenotypes. Public Library of Science 2013-03-28 /pmc/articles/PMC3610872/ /pubmed/23555978 http://dx.doi.org/10.1371/journal.pone.0060475 Text en © 2013 Capra et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Capra, Valérie
Busnelli, Marta
Perenna, Alessandro
Ambrosio, Manuela
Accomazzo, Maria Rosa
Galés, Celine
Chini, Bice
Rovati, G. Enrico
Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
title Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
title_full Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
title_fullStr Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
title_full_unstemmed Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
title_short Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
title_sort full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and g protein activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610872/
https://www.ncbi.nlm.nih.gov/pubmed/23555978
http://dx.doi.org/10.1371/journal.pone.0060475
work_keys_str_mv AT capravalerie fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation
AT busnellimarta fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation
AT perennaalessandro fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation
AT ambrosiomanuela fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation
AT accomazzomariarosa fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation
AT galesceline fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation
AT chinibice fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation
AT rovatigenrico fullandpartialagonistsofthromboxaneprostanoidreceptorunveilfinetuningofreceptorsuperactiveconformationandgproteinactivation